Company intelligence / Profile preview

Harbin Tongyitang Pharmaceutical

Harbin, Heilongjiang, China

Ownership: Private
Development stage: Other

Overview

Harbin Tongyitang Pharmaceutical is a subsidiary pharma company in Heilongjiang, China, mainly engaged in development and manufacturing of traditional Chinese medicines and generic drugs; current clinical research includes a bioequivalence study of metformin hydrochloride extended-release tablets, and quality controls on TCM-based products such as Zhibituo Dropping Pills, with no innovative NMEs in advanced clinical development identified as of August 2025[7].

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Small moleculeTraditional Chinese medicine
Industry: Biotech

Beyond the preview

Go deeper on Harbin Tongyitang Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harbin Tongyitang Pharmaceutical.

Explore the full profile